Yesterday, eMagin Corporation announced that it has commenced a 2-year, $6 million program to develop an ultra-high resolution OLED microdisplay. Managed by the Telemedicine and Advanced Technology Research Center of the US Army Medical Research and Materiel Command, the program introduces the third phase of a multiple year effort to provide a prototype of an ultra-high resolution display system suitable for several applications within Army medicine and military simulation and training.

The Widescreen Ultra eXtended Graphics Array (WUXGA) microdisplay will be sized for a less than one-inch diagonal with over 7 million pixels at a 9.6 micron color pixel pitch. The program involves optic design for a wide field-of-view between 60 and 80 degrees.

Currently, eMagin’s OLED microdisplays already meet military specifications across diverse applications, including IR night vision and tactical situational awareness HMDs, in addition to being integrated into commercial devices such as thermal video cameras and video gaming systems.

Susan

Siemens Corporate Research spin-off and Speedus Corp. subsidiary, Zargis Medical Corp., announced Friday that it has received U.S. Food and Drug Administration clearance to market the new Signal X6(TM) device. The company also announced that seven Signal X6 devices have been delivered to the U.S. Army for deployment in six Department of Defense medical facilities.

Signal X6 technology records heart and lung sounds from six adhesive sensors. The recordings can be evaluated locally or, when a cardiac specialist is not immediately available, transmitted through the Internet for remote evaluation. This feature makes the noninvasive technology easy to use. The configuration of the Signal X6 provides a unique telemedicine resource in situations where evaluations could benefit from high fidelity multi-channel synchronous recordings.

Prototypes for Signal X6 were first developed with funding from the Telemedicine and Advanced Technology Research Center (TATRC), of the USAMRMC, through the AAMTI program. The AAMTI program provides funding to

New Mexico Software, Inc., a leading developer and provider of medical IT services and solutions that enable improved and faster communication, announced its financial results for the second quarter ended June 30, 2009.

Second Quarter 2009 Financial Highlights Include:

– Total revenue increased 345% to $902,000 from $202,000 in Q2 2008

– Six month revenue rose 318% to $1,828,000 from $437,000 in the first half of 2008

– Cash and cash equivalents totaled $65,000, a decrease from $103,000 as of March 31, 2009

– Gross profit increased 259% to $226,000 from $63,000 in Q2 2008

– Net loss decreased to ($63,000) from ($172,000) a year ago

“Our key indicator of operating progress is gross revenue,” CEO Dick Govatski stated. “As we continue to grow our variable costs begin to constitute a greater percentage of our cost of sales, the gross profit percentage will vary more consistently with revenue making gross profit

span class=”Apple-style-span” style=”font-weight: bold;”Authentidate Holding Corp (ncm: ADAT) $0.27/span- Authentidate is attractively positioned to benefit from the expected flood of spending aimed at modernizing healthcare IT. Remote patient monitoring, also known as telehealth, is one area where Authentidate stands to capitalize due to its unique and superior product solution. Patient home monitoring is expected to be a $12 billion industry by 2012. ADAT will earn $120M in revenue if it achieves just 1% penetration. This compares to $6M in revenue Authentidate earned last fiscal year. There are a decent number of patient monitoring devices deployed currently, yet very few have actual “telemedicine” functionality, whereby a patient’s vitals are electronically transmitted to the healthcare provider coupled with any patient instructions subsequently relayed back to the patient. According to an InMedica study, there were less than 1 million telehealth subscribers in 2008, yet that number is expected to climb to over 55 …